The Pt(S-pr-thiosal)2 and BCL1 Leukemia Lymphoma: Antitumor Activity In Vitro and In Vivo

B cell malignancies are, despite the development of targeted therapy in a certain percentage of the patients still a chronic disease with relapses, requiring multiple lines of therapy. Regimens that include platinum-based drugs provide high response rates in different B cell lymphomas, high-risk chr...

Descripción completa

Detalles Bibliográficos
Autores principales: Silconi, Zana Besser, Rosic, Vesna, Benazic, Sasa, Radosavljevic, Gordana, Mijajlovic, Marina, Pantic, Jelena, Ratkovic, Zoran R., Radic, Gordana, Arsenijevic, Aleksandar, Milovanovic, Marija, Arsenijevic, Nebojsa, Milovanovic, Jelena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332548/
https://www.ncbi.nlm.nih.gov/pubmed/35897737
http://dx.doi.org/10.3390/ijms23158161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332548/
https://www.ncbi.nlm.nih.gov/pubmed/35897737
http://dx.doi.org/10.3390/ijms23158161

Ejemplares similares